EndoC-bH3 — PKBSM3459GAGF
Summary
EndoC-bH3 cell line, depleted of Cas9 RNP, HNF1A
Sample Terms
Sources
Sample Name
EndoC-bH3
Classifications
human beta cell line
Growth Medium
Advanced DMEM/F12 supplemented with 2% fatty acid-free Bovine Serum Albumin Fraction V, 6.7 ng/mL sodium selenite, 50 μM 2-mercaptoethanol, 5.5 μg/mL human transferrin, 10 mM nicotinamide, 1% GlutaMAX and 100 U/mL Penicillin-Streptomycin
Age
unknown
Coating Condition
ECM, fibronectin
Excision Status
unknown
Description
EndoC-bH3 cells treated with HNF1A sgRNA and CRISPR-Cas9 RNPs from GSE277551
Publication Identifiers
File SetsReport view
2 items
Treatments
2 items
Attribution
Funding
Supported by National Institutes of Health (NIH) grants U24 DK138515, U24 DK138512
Supplemental funds from the NIH Office of Data Science Strategies
Supplemental funds from the NIH Office of Data Science Strategies
